In the BioHarmony Drug Report Database

"Preview" Icon

Levetiracetam

Elepsia, Keppra, Levetiracetam, Spritam (levetiracetam) is a small molecule pharmaceutical. Levetiracetam was first approved as Elepsia on 1999-11-30. It is used to treat epilepsy, juvenile myoclonic epilepsy, partial epilepsies, and tonic-clonic epilepsy in the USA. It has been approved in Europe to treat epilepsy. The pharmaceutical is active against synaptic vesicle glycoprotein 2A. Keppra’s patents are valid until 2034-03-14 (FDA).

 

Trade Name

 

Keppra
 

Common Name

 

levetiracetam
 

ChEMBL ID

 

CHEMBL1286
 

Indication

 

epilepsy, juvenile myoclonic epilepsy, partial epilepsies, tonic-clonic epilepsy
 

Drug Class

 

Nootropes (piracetam type)

Image (chem structure or protein)

Levetiracetam structure rendering